Primary Health Properties stock reports GBP 197 million revenue

Primary Health Properties stock was trading at GBp 92.20 on the London Stock Exchange at 10:10 a.m. London time on September 24, 2026, down 0.65 percent from the prior session. The healthcare property group reported GBP 197 million in quarterly revenue and GBP 99 million in net income for the quarter ended June 30, 2026.

June quarter shows scale

According to The Globe and Mail, the June quarter revenue figure compared with GBP 89.7 million in the prior-year quarter, while net income rose from GBP 59.4 million. The comparison puts the revenue increase at GBP 107.3 million and the net income increase at GBP 39.6 million.

The finance data for Q2 2026 also shows GBP 197 million in revenue, GBP 99 million in net income and earnings per share of GBP 0.04. Those figures make the quarter a useful reference point for the share price, because the stock is trading below the reported earnings period's operating peak while the property portfolio remains a central valuation driver.

Dividend income remains central

Primary Health Properties paid a quarterly dividend of GBp 1.825 per share on August 14, 2026, according to DividendRegistry. The payment is one of the key figures for income-oriented investors, particularly because the share price stood at GBp 92.20 while the 52-week range ran from GBp 87.40 to GBp 109.60.

The company describes its primary listing as the London Stock Exchange on its investor page. Its portfolio is concentrated in healthcare properties with long leases, making rental income and financing costs the main variables behind the earnings picture.

Analyst target exceeds market price

Berenberg reiterated a Buy rating and set a GBp 133.00 price target on August 15, 2026, according to The Globe and Mail. The target stands GBp 40.80 above the September 24 price, a gap of 44.25 percent, so the analyst view and the live market quote point to different valuation levels.

Stock stays inside yearly range

Primary Health Properties stock stood 5.49 percent above its 52-week low and 15.88 percent below its 52-week high on September 24, 2026. The combination of a 0.65 percent daily decline, a GBP 99 million quarterly profit and a GBp 133.00 analyst target gives investors three concrete reference points for assessing the healthcare REIT.